# Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions.

> **NCT03721614** · NA · UNKNOWN · sponsor: **Meril Life Sciences Pvt. Ltd.** · enrollment: 200 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** BioMime™ Morph - Sirolimus Eluting Coronary Stent System
- **DEVICE:** Xience family Everolimus Coronary Stent Systems

## Key facts

- **NCT ID:** NCT03721614
- **Lead sponsor:** Meril Life Sciences Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-15
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-06-22
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03721614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03721614, "Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions.". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT03721614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*